[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100318018":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":12,"locations":28,"responsibleParty":42,"collaborators":45,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":12,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":12,"enrollmentInfo":62,"targetDuration":12,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":78,"whyStopped":12,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Erasmus Medical Center","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group","NO_INTERVENTION","Control group will receive standard care alone.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Home monitoring group","EXPERIMENTAL","Intervention will consist of a home monitoring program added to standard care.",[18],"Other: Home monitoring program",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Home monitoring program","The home monitoring program consists of 1) the use of an interactive internet tool to coach patients and enhance self-management 2) home-based pulmonary function testing with a handheld spirometer and 3) recording of patient-reported outcomes (PROs).",[14],[25],{"name":26,"affiliation":5,"role":27},"Marlies Wijsenbeek, MD PhD","PRINCIPAL_INVESTIGATOR",[29],{"facility":30,"status":12,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":12},"Erasmus MC","Rotterdam","South Holland","3015 CE","Netherlands","NL",{"type":37,"coordinates":38},"Point",[39,40],4.47917,51.9225,{"lat":40,"lon":39},{"type":27,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Marlies Wijsenbeek","Dr. M.S. Wijsenbeek, pulmonologist, Principal Investigator",[46,49,51],{"name":47,"class":48},"OLVG","NETWORK",{"name":50,"class":6},"St. Antonius Hospital",{"name":52,"class":6},"Zuyderland Medical Centre","100318018","home-monitoring-in-idiopathic-pulmonary-fibrosis-improving-use-of-anti-fibrotic-medication-and-quality-of-life-100318018",false,"NCT03420235","Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life","Inclusion Criteria:\n\n* All patients with a diagnosis of IPF according to the ATS 2011 criteria and about to start on anti-fibrotic treatment (either nintedanib or pirfenidone)\n\nExclusion Criteria:\n\n* Not able to speak, read or write in Dutch\n* No access to internet",true,"ALL","18 Years",{"count":63,"type":64},90,"ACTUAL","INTERVENTIONAL",[67],"NA","In this study it will be investigate whether a home monitoring program improves disease-specific health-related quality of life (HRQOL) for patients with idiopathic pulmonary fibrosis (IPF) through appropriate medication use and subsequently results in better objective and subjective outcomes.",[70],"Idiopathic Pulmonary Fibrosis",[72,73,74,75,76,77],"quality of life","eHealth","patient-reported outcomes","home spirometry","cost-effectiveness","home monitoring","COMPLETED","2020-01-29",{"date":81,"type":64},"2020-01-30",{"date":83,"type":64},"2018-01-09",{"date":85,"type":64},"2019-08-26",{"name":5,"class":6},1]